Depomed (DEPO) Tops Q4 EPS by 5c
Tweet
Share
E-mail
Get Alerts DEPO Hot Sheet
Join SI Premium – FREE
Depomed (NASDAQ: DEPO) reported Q4 EPS of $0.15, $0.05 better than the analyst estimate of $0.10. Revenue for the quarter came in at $94 million versus the consensus estimate of $90.94 million.
For earnings history and earnings-related data on Depomed (DEPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Gap, Inc. (GAP) Tops Q2 EPS by 3c
- SentinelOne, Inc. (S) Tops Q2 EPS by 1c; offers guidance
- PagerDuty, Inc. (PD) Tops Q2 EPS by 1c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
